[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Dacima Consulting\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":92},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,67],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100587908",false,"NCT06934499","Tunisian Lung Cancer Study","Clinical Observational Study on Tunisian Lung Cancer","LUNG-TUN","Inclusion Criteria:\n\n* Age more than 18 years\n* Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and\u002For by cytology, at least 3 months before the inclusion date\n* Informed consent\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":19,"type":20},1334,"ESTIMATED","12 Months","OBSERVATIONAL","This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.",[25],"Pulmonary Cancer",[25,27,28],"Registry","Tunisia","RECRUITING","2025-06-02",{"date":32,"type":33},"2025-06-04","ACTUAL",{"date":35,"type":33},"2025-05-02",{"date":37,"type":20},"2026-10-30",{"name":39,"class":40},"Dacima Consulting","OTHER",2,{"id":43,"slug":4,"hasResults":10,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":49,"targetDuration":51,"studyType":22,"phases":4,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":4},"100579533","NCT06825533","The Prevalence of Prediabetes in Primary Care Medicine in Tunisia","The Prevalence of Prediabetes in Primary Care Medicine in Tunisia. a National Descriptive Cross-Sectional Study","TUN-PREDIAB","Inclusion Criteria:\n\n* Ambulatory patient consulting in primary care in a public or private structure\n\nExclusion Criteria:\n\n* Known diabetes\n* Concomitant medication that may influence blood sugar (corticosteroids, metformin, GLP1 analogues, SGLT2 inhibitor)\n* Severe, acute or chronic comorbidity (end-stage renal failure, severe liver disease, heart failure)\n* Severe anemia\n* Pregnancy",{"count":50,"type":20},5000,"1 Day","The study is national, observational and cross-sectional and aims to estimate the prevalence of prediabetes in primary care in Tunisia.",[54],"Prediabetes",[54,56,57],"STMGF","Survey","NOT_YET_RECRUITING","2025-02-23",{"date":61,"type":33},"2025-02-25",{"date":63,"type":20},"2025-04-21",{"date":65,"type":20},"2025-08-21",{"name":39,"class":40},{"id":68,"slug":4,"hasResults":10,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":10,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":73,"targetDuration":51,"studyType":22,"phases":4,"briefSummary":75,"conditions":76,"keywords":79,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},"100550281","NCT06445036","Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism","THYPARS","Inclusion Criteria:\n\n* Hypoparathyroidism defined by low serum calcium \\\u003C 2.2 mmol\u002Fl (\\\u003C 88 mg\u002Fl) associated with inadequate PTH (low or normal) and normal creatinine\n\nExclusion Criteria:\n\n* Cervical surgery \\\u003C 6 months.\n* Transient (neonatal, etc.) or functional (dysmagnesemia, etc.) hypoparathyroidism.\n* Other causes of hypocalcemia: vitamin D deficiency, chronic renal failure, etc.\n* Familial hypocalcemia hypercalciuria.\n* Pseudo-pseudo-hypoparathyroidism.",{"count":74,"type":20},1000,"Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.",[77,78],"Hypoparathyroidism","Pseudo Hypoparathyroidism",[77,78,80,81,82],"Clinical Registry","Endocrinology","Parathyroid gland","2025-02-20",{"date":85,"type":33},"2025-02-21",{"date":87,"type":20},"2025-02-27",{"date":89,"type":20},"2025-07-27",{"name":39,"class":40},1,""]